BACKGROUND:One of the big roadblocks in development of HIV-1/AIDS vaccines is the enormous diversity of HIV-1. which could limit the value of any HIV-1 vaccine candidate currently under test. METHODOLOGY AND FINDINGS:To address the HIV-1 variation. we designed a novel T cell immunogen. https://www.campicon.com/